Join
Live feed
·
INSIDERFilingvia Quantisnow
Outlook Therapeutics Inc. logo

SEC Form 4: Sukhtian Faisal Ghiath bought $38,700 worth of shares (30,000 units at $1.29), increasing direct ownership by 79% to 68,000 units

ByQuantisnow·Wall Street's wire, on your screen.
OTLK· Outlook Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OTLK (Outlook Therapeutics Inc.) and more on Quantisnow.